Vinge advises Ballingslöv in Stena Adactum’s public offer

June 13, 2008

Vinge is advising the board of directors of Ballingslöv International AB (publ) in connection with Stena Adactum AB’s announced public offer for Ballingslöv. The total value of the offer amounts to approximately SEK 1,222 million.

The Vinge team advising Ballingslöv includes partner Göran Nyström and associate Jonas Johansson. 


Vinge advises Calliditas Therapeutics in connection with Asahi Kasei Corporation’s public takeover offer

On 28 May 2024, Asahi Kasei Corporation announced a public takeover offer to the shareholders and holders of American Depositary Shares in Calliditas Therapeutics AB (publ) (”Calliditas Therapeutics”) to acquire all shares and American Depositary Shares (each representing two shares) in Calliditas Therapeutics.
May 28, 2024

Vinge has advised Alder on the establishment of Alder III

Vinge has advised Alder on the establishment of Alder's third and largest fund to date, Alder III.
May 27, 2024